Global research trends and hotspots in human immunodeficiency virus-associated cervical cancer (1990–2025): a multi-database bibliometric analysis

• by Lin Sui, Rutie Yin

• June 10, 2026

Long-read sequencing for cancer liquid biopsy: advancing precision oncology

• by Grace Guzman, Analiz Rodriguez

• June 10, 2026

Case Report: Alectinib and CNS-directed therapy for primary or relapsed ALK-positive anaplastic large cell lymphoma with central nervous system involvement

• by Milda Mikalonytė, Vilhelmas Landsbergis, Lukas Kevličius, Skirmantė Černauskienė, Linas Davainis, Andrius Žučenka, Igoris Trociukas, Regina Pileckytė, Birutė Davainienė, Inga Šlepikienė, Gintarė Ražanskienė, Ugnius Mickys, Jonas Ražanskas, Jūratė Dementavičienė, Mindaugas Stoškus, Raminta Batiuškaitė, Laimonas Griškevičius

• June 9, 2026

This Week’s Biopharma News: Big Moves in Bispecifics

Akeso’s PD-1/VEGF bispecific beats PD-1 plus chemo in lung cancer, Amgen wins EC approval for its DLL3-targeted T-cell engager, and Aragen scales Renaissance’s Fast Track anti-GD2 antibody

• June 9, 2026

• 5 min